Trial Profile
Investigating Bone Density and Bone Loss Without Baseline Information
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Jun 2023
Price :
$35
*
At a glance
- Drugs Letrozole (Primary) ; Tamoxifen (Primary)
- Indications Early breast cancer
- Focus Adverse reactions; Biomarker; Pharmacodynamics
- 17 Jun 2016 New trial record